Dual Energy X-ray Absorptiometry (DEXA) ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
299	Cystic fibrosis	2

299. Cystic fibrosis

---

Clinical trials : 1,696 /  Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00287443 (ClinicalTrials.gov)	February 2, 2006	2/2/2006	Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis		Cystic Fibrosis	Procedure: Oral Glucose tolerance test;Procedure: Whole body protein turnover;Procedure: IV glucose tolerance test;Procedure: Indirect Calorimetry;Procedure: Dual Energy X-ray Absorptiometry (DEXA);Procedure: Growth Hormone Stimulation Test	University of Texas Southwestern Medical Center	Genentech, Inc.	Withdrawn	7 Years	17 Years	All	0	N/A	United States
2	NCT00287430 (ClinicalTrials.gov)	January 2006	2/2/2006	Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis		Cystic Fibrosis	Drug: Growth Hormone;Procedure: Whole body Protein Turnover Study;Procedure: Dual Energy X-ray Absorptiometry (DEXA)	University of Texas Southwestern Medical Center	Dana S Hardin	Withdrawn	6 Years	40 Years	All	0	N/A	NULL